After President Trump dominated the market narrative in his first week in office, a Fed meeting, a check on the health of the ...

When Santander boss Ana Botin met Rachel Reeves at the annual Davos jamboree last week, the atmosphere may have been frostier ...

JPMorgan Chase & Co. (NYSE:JPM) has successfully closed public offerings of various notes totaling $8 billion on Thursday, ...

The bank's supplementary leverage ratio was 6.1% at the end of fourth quarter of 2024, in excess of the minimum of 5%. JPMorgan's liabilities are prudently diversified, with more than half of assets ...

Kevin Willsey, a JPMorgan Chase & Co. global chair of investment banking and capital markets, is retiring after more than ...

In a remarkable display of financial resilience, JPMorgan Chase (NYSE:JPM) & Co. stock soared to an all-time high, reaching a price level of $266.82. The all-time high represents not just a peak in ...

Meta CEO Mark Zuckerberg announced this morning that the company intends to spend $60B-$65B in capital expenditures for the year, which RBC ...

In a report released yesterday, Jon Arfstrom from RBC Capital maintained a Buy rating on SLM (SLM – Research Report), with a price target of ...

Stocks in the oil-and-gas sector fared better than the broader European market in a downbeat end to the year, with the Stoxx Europe 600 Oil & Gas sector index down 0.1% in the fourth quarter compared ...

JPMorgan Chase produced one of the best quarterly results of its peer growth relative to expectations. Learn more about JPM ...

Emerging markets could be seeing a dreaded "sudden stop" of capital flows as President Donald Trump's 'America First' policies pump up the U.S. economy and suck money away from poorer countries, ...

What are biopharma VCs looking to invest in this year? Autoimmune disorders, osteoporosis, and cardiovascular disease are ...